Psyence Biomedical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	7.15	6.14	0.73	1.33	1.76
Cash & Short-Term Investments	7.15	6.14	0.73	1.33	1.76
Cash Growth	269.98%	736.78%	-45.05%	-23.97%	-
Other Receivables	0.17	0.14	0.04	0.15	0.04
Receivables	0.17	0.14	0.04	0.15	0.04
Prepaid Expenses	0.26	0.25	0.32	0.08	0.01
Restricted Cash	0.05	0.04	0.03	0.03	0.03
Total Current Assets	7.63	6.56	1.13	1.59	1.83
Property, Plant & Equipment	0.01	0.01	0.01	-	-
Long-Term Investments	5.17	0.75	-	-	-
Total Assets	12.81	7.32	1.13	1.59	1.83
Accounts Payable	0.24	0.26	0.56	1.63	0.04
Accrued Expenses	0.1	0.05	0.13	0.16	0.09
Short-Term Debt	-	-	10.45	-	-
Other Current Liabilities	0.6	0.28	0.97	-	-
Total Current Liabilities	0.94	0.59	12.1	1.79	0.13
Total Liabilities	0.94	0.59	12.1	1.79	0.13
Common Stock	68.88	61.75	46.13	5.93	1.7
Retained Earnings	-58.44	-56.45	-57.46	-6.3	-
Comprehensive Income & Other	1.42	1.42	0.36	0.17	-
Shareholders' Equity	11.87	6.72	-10.97	-0.2	1.7
Total Liabilities & Equity	12.81	7.32	1.13	1.59	1.83
Total Debt	-	-	10.45	-	-
Net Cash (Debt)	7.15	6.14	-9.71	1.33	1.76
Net Cash Growth	1032.45%	-	-	-23.97%	-
Net Cash Per Share	10.09	31.78	-891.01	-	-
Filing Date Shares Outstanding	1.87	0.57	0.02	-	-
Total Common Shares Outstanding	1.87	0.57	0.02	-	-
Working Capital	6.69	5.97	-10.98	-0.2	1.7
Book Value Per Share	6.34	11.83	-489.80	-	-
Tangible Book Value	11.87	6.72	-10.97	-0.2	1.7
Tangible Book Value Per Share	6.34	11.83	-489.80	-	-
Machinery	0.02	0.02	0.01	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q